exclusion of subject due to vomiting [Regulatives / Guidelines]

posted by ratnakar1811 – India, 2011-06-20 08:37 (5485 d 18:03 ago) – Posting: # 7155
Views: 11,365

Dear HS,
Thanks for your inputs;

❝ Withdraw a subject if vomiting occurs according to FDA’s rules. Analyze samples – regardless the treatment.


My concern is current EU guideline specifically mention about the decesion to withdraw a subject should be taken before analysis & this should not creat any issues later on, as I got a study where withdrwing a subject at statistical analysis stage reverse the results of the study?

Best Regards,

Ratnakar

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
414 visitors (0 registered, 414 guests [including 33 identified bots]).
Forum time: 02:40 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5